GeneFerm Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	278.95	280.26	122.45	120.15	100.69	539.61
Cash & Short-Term Investments	278.95	280.26	122.45	120.15	100.69	539.61
Cash Growth	8.43%	128.88%	1.91%	19.33%	-81.34%	55.05%
Accounts Receivable	76.76	97.93	101.56	117.6	120.98	104.66
Other Receivables	15.92	15.83	15.22	0.15	0.46	0.24
Receivables	92.68	113.76	116.78	117.75	121.44	104.9
Inventory	190.22	190.23	165.87	155.43	142.61	114.83
Prepaid Expenses	15.11	-	-	3.8	8.81	5.84
Other Current Assets	-	11.23	6.87	-	-	-
Total Current Assets	576.96	595.48	411.97	397.13	373.54	765.18
Property, Plant & Equipment	664.17	663.58	708.46	761.95	734.28	510.39
Other Intangible Assets	1.02	1.16	1.7	2.02	1.1	1.4
Long-Term Deferred Tax Assets	9.7	9.88	14.37	8.87	8.66	7.7
Other Long-Term Assets	10.36	10.55	9.99	5.41	72.05	32.22
Total Assets	1,262	1,281	1,146	1,175	1,190	1,317
Accounts Payable	21.19	16.15	23.77	33.2	49.93	39.08
Accrued Expenses	-	54.28	46.71	58.39	51.9	40.95
Short-Term Debt	-	-	-	40	45	-
Current Portion of Long-Term Debt	-	33.16	24.43	5.25	26	308.65
Current Portion of Leases	6.57	6.26	5.42	6.04	5.97	5.19
Current Income Taxes Payable	1.82	1.82	-	19.01	10.28	13.42
Current Unearned Revenue	24.02	23.95	12.49	5.78	7.63	8.29
Other Current Liabilities	124.22	23.04	21.43	22.18	42.52	15.6
Total Current Liabilities	177.82	158.64	134.26	189.86	239.22	431.18
Long-Term Debt	197.09	205.38	126.54	-	5.25	31.25
Long-Term Leases	84.99	79.44	78.53	76.15	98.8	92.13
Pension & Post-Retirement Benefits	-	20.53	18.88	16.52	15.59	14.66
Long-Term Deferred Tax Liabilities	0.05	0.01	0.1	-	-	-
Other Long-Term Liabilities	20.84	0.01	0.01	0.01	0.01	0.01
Total Liabilities	480.79	464	358.31	282.54	358.86	569.22
Common Stock	414.6	414.6	414.6	414.6	414.6	407.89
Additional Paid-In Capital	294.34	294.34	294.34	294.34	294.34	270.69
Retained Earnings	74.13	109.84	81.38	186.69	124.26	72.27
Comprehensive Income & Other	-1.63	-2.11	-2.13	-2.79	-2.43	-3.19
Shareholders' Equity	781.43	816.66	788.18	892.84	830.77	747.66
Total Liabilities & Equity	1,262	1,281	1,146	1,175	1,190	1,317
Total Debt	288.65	324.23	234.92	127.44	181.02	437.22
Net Cash (Debt)	-9.7	-43.97	-112.47	-7.29	-80.33	102.39
Net Cash Per Share	-0.23	-1.06	-2.71	-0.18	-1.89	2.21
Filing Date Shares Outstanding	41.46	41.46	41.46	41.46	41.46	40.79
Total Common Shares Outstanding	41.46	41.46	41.46	41.46	41.46	40.79
Working Capital	399.15	436.85	277.71	207.27	134.32	334
Book Value Per Share	18.85	19.70	19.01	21.53	20.04	18.33
Tangible Book Value	780.41	815.5	786.48	890.82	829.67	746.27
Tangible Book Value Per Share	18.82	19.67	18.97	21.49	20.01	18.30
Land	-	15.44	15.44	15.44	15.44	15.44
Buildings	-	457.57	457.26	260.87	259.44	255.46
Machinery	-	837.21	825.29	822.26	725.62	536.67
Construction In Progress	-	-	-	194.02	184.12	127.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.